Jan 27, 2023
January 25, 2025
This week’s newsletter included:
-
DiscGenics Announces Positive Two-Year Clinical Data
-
DiscGenics Gets FDA Regenerative Medicine Advanced Therapy Designation
-
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
-
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD
-
Intermountain Healthcare Is Now “Intermountain Health”
-
WalletHub Ranks Utah as Best State to Start a Business
-
Altitude Lab Hosts The RISE Summit
-
Altitude Lab Hosts Demo Day – PEEL Therapeutics Chosen People’s Choice Award
-
KolosisBio Announces Strong 2022 Results
-
Biomerics Completes Connecticut Expansion
-
HOSA Judging Opportunity
-
100 Companies Championing Women Nomination Application
Featured New Member: Diagnostic Ventures
Recent News
- Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
- Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
